BULUMTATUG FUVEDOTIN
UNII 3L9KU8WUU3

Substance Identification & Data

This profile provides standardized clinical and technical data for Bulumtatug Fuvedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3L9KU8WUU3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2862919-82-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3L9KU8WUU3
CAS Registry Number
2862919-82-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BULUMTATUG FUVEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13081
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bulumtatug Fuvedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BULUMTATUG FUVEDOTIN

Common Names & Synonyms

BULUMTATUG FUVEDOTIN [INN]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS NECTIN4 (NECTIN-4, NECTIN CELL ADHESION MOLECULE 4, PVRL4, POLIOVIRUS RECEPTOR-RELATED 4, PPR4, LNIR)), CONJUGATED ON AN AVERAGE OF 8 CYSTEINYL RESIDUES TO MONOMETHYLAURISTATIN E (MMAE), WITH A RATIO OF 1 TO 4, VIA A CLEAVABLE DIVALENT LINKER